Zurueck zur Suche

Reporte zur Charge U6089AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
FL 1

VAERS 972085

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge U6089AA

mild
Staat
FL
Alter
28,0
Geschlecht
M
Eingang
25.01.2021
Impfdatum
14.09.2020
Beginn
14.09.2020
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Clostridium test Corynebacterium test Inflammation Injection site erythema Injection site haemorrhage Injection site oedema Pain Poliovirus test

Symptomtext

Further vaccine site details not recorded. 28 yo healthy male experienced severe local erythema, edema and ecchymosis at injection site left upper arm after receipt of Tdap #2, anthrax #5 and IPV #9. Initially no immediate reaction. By evening he developed increasing pain followed be edema, warmth, erythema and ecchymosis but diminishment of pain. Local inflammation symptoms peaked day two and are improved today on day3. He has some pain with lateral motion but is otherwise performing usual activities other than weight No systemic symptoms otherwise feels well. Symptoms limited to affected area on upper arm.. He reports a similar reaction 24 February 2020 which vaccine receipt included IPV #8 (lot #P1f541M) and anthrax #4 (#300031A) JEV #2 (JEV18C74E) and IIV #10 (P100139893, SKB). This event was characterized by more erythema and edema but no ecchymosis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
We performed titers to POLIO VIRUS ANTIBODY TYPE 1 & 3 which resulted at > 1:320 , Tetanus antibody which resulted at >7.0 and diphtheria antibody which resulted at >3.0.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
severe erythema edema, pain at upper arm injection site periphery